Application for 3 PhD Positions
The IRTG 2804 “Women’s mental health across the reproductive years” now welcomes applications for our PhD positions in the field of neuroimaging, psych neuroendocrinology and sociology! 3 PhD positions are available for 3 years starting on 01.01.2023! Please refer to our website:
· Project 02 Stress reactivity and stress regulation in relation to estradiol administration
· Project 03 Stress reactivity and hormonal contraception
· Project 11 Gender identity and norms and psychosocial function across hormonal transition (dates may vary for this project, please see the application website)
The University of Tübingen is an equal opportunities employer. Applications of women are thus especially encouraged; applications of disabled persons will be given preferential treatment to those of other candidates with equal qualifications.
· An interdisciplinary and international research environment
· A structured PhD program with the opportunity to develop your individual skillset
· Intensive support, mentoring and career development
· A stay in Swedens science hub Uppsala University for 6 months
· Payment is based on the German TV-L scale (E13, 65%)
· Enthusiasm for interdisciplinary research
· Scientific interest in the topic of women’s mental health
· Interest and openness to work together with our international partners
· Willingness to stay at Uppsala University for 6 months
· Social competence and ability to work in a team
· Excellent English language skills
Please submit the following documents: CV, letter of motivation, research exposé outlining your research interests with reference to the goals of this IRTG, contact information of two referees, as well as all relevant certificates until the 11.12.2022.
Applications will be screened by the steering committee and qualified candidates will be selected for an online recruitment symposium which will be held in after an initial screening of the applicants. Primary selection criterion is scientific excellence as mirrored in a timely graduation with excellence, a relevant and experimental bachelor/master thesis, as well as a match of expressed research interests with the IRTG’s goals.
For more information, please visit our website: http://www.irtg2804.de
The Hertie Institute for Clinical Brain Research (Research Division Translational Genomics of Neurodegenerative Diseases, Dept. of Neurodegenerative Disease) is inviting applications for a PhD student, TVL E13, 65%, 3 years (extension possible) in fluid biomarkers for neurodegenerative diseases
The Hertie Institute for Clinical Brain Research (HIH), together with the Department of Neurology, forms the Center for Neurology at the University of Tuebingen. It is dedicated to basic and translational research in neurological diseases. Together with the several other highly advanced neuroscience institutes, it is part of the TuebingenNeuroCampus (TNC), here working closely together also with the German Center for Neurodegenerative Diseases (DZNE). Scientists in the more than 100 active research groups of the TNC pursue theoretical, system-neuroscientific, molecular, and clinical research approaches in their entire breadth using a wide range of methods.
The research division „Translational Genomics of Neurodegenerative Diseases“ of Prof. Synofzik focuses on genomics, pathophysiology and translational biomarker research in the field of neurodegenerative diseases, with a special focus on genetic ataxias, motor neuron diseases, and dementias. Prof. Synofzik coordinates several large trans-European consortia on translational neurodegeneration in rare movement disorders and serves as PI of several large-scale national and international longitudinal cohort studies. We offer excellent projects and training in neurodegeneration and molecular biology research. A wide range of molecular, protein biochemical and cell biological methods are applied in the lab (e.g. exome/genome sequencing, Sanger sequencing, qPCR, western blotting, ELISAs, and cutting-edge ultra-sensitive protein analysis including Simoa, Luminex and Singulex technology). Biomarkers are identified in cell culture models, human and murine blood and/or CSF, and validated in patient cohorts.
The PhD project. You will be integrated in several translational projects as the key person to identify and validate novel fluid biomarkers in dementia (fronto-temporal dementia and Alzheimer`s disease) and ataxia disorders (ARSACS and COQ8A). You will identify novel biomarkers in fluids from humans, mice and cell culture disease models with unbiased mass spectrometry proteomics and targeted immunoassays. You will receive an excellent training in cutting-edge molecular biology methods and assay development (including MSD, Simoa, Singulex and Luminex technology, which are all directly available and established on site), collaborate with biotechnology cores across the Tuebingen research campus, and work collaboratively with our team to report the results and progress at conferences and scientific journals.
This position will be funded by the ‘Bundesministerium fuer Bildung und Forschung’ (BMBF) via funding for the European Joint Programme Rare Diseases 2020 (EJPRD) and the Elite Post-Doc Program of the Baden-Wuerttemberg Foundation.
What we are looking for:
What we are offering: We offer a challenging interdisciplinary translational project that is integrated into major national and European research consortia at the interface of genomics and translational medicine, well-equipped laboratories with top-notch facilities, excellent supervision in a highly collaborative international environment and affiliation with the Graduate Training Center of Neuroscience. The position is available immediately. Salary will be determined according to the German collective wage agreement in public service (TVL 13, 65%). Appointment is full time and will be initially for three years with the possibility of extension. We give priority to severely disabled applicants with essentially equal qualifications.
Application: If you are interested in this project, please send your full application within one PDF file. This should include:
Please send this PDF to: Mrs Selina Reich (Research Division Prof. Synofzik): firstname.lastname@example.org
Application Deadline: 18.11.2022
Sincerely, Matthis Synofzik
Head, Research Division Translational Genomics of Neurodegenerative Diseases
Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research